ARCHIVES

In Brief: Durant To Leave Alabama, Will Become President, Chief Executive Officer At Fox Chase Cancer Center

This article is from The Cancer Letter archive.

Vol. 08 No. 36 | September 17, 1982

Download PDF Visit The Full Archive

Related Articles

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

Garb’s Questions, Answers About Cancer Program

December 12, 1980

Research Triangles Lands Plant Drug Contract Renewal

April 9, 1976

NCAB Approves Bypass Budget f $1.685 Billion for FY ’88, $200 Million More Than Asked For ‘87

May 30, 1986

Miami HIV Trials Unit Forced To Turn Some Patients Away

January 10, 1992

Foundations: Biomedical Foundation Formed to Support NIH

September 27, 1996